[1]吴晓蔓, 刘海涛.HBV-DNA定量和定性PCR反应及临床实用性的探讨[J].临床肝胆病杂志, 2000, 16 (4) ∶226~227.
|
[2]Neurath AR, Kent SB, Strick N, et al.Identification and chemicalsynthesis of a host cell receptor binding site on hepatitis B virus[J].Cell, 1986, 46∶429-431.
|
[3]张永宏, 赵艳, 胡中杰.乙型肝炎病毒抗原临床意义分析[J].临床荟萃, 2001, 16 (24) ∶1111-1113.
|
[4]冯福民, 米志宝, 王洪莉, 等.前S1蛋白在乙型肝炎诊断、治疗和预后中的作用[J].中西医结合肝病杂志, 1997, 7 (1) ∶18-21.
|
[5]Hu KQ.Occult hepatitis B virus infection and its clinical implica-tions[J].J Viral Hepat, 2002, 9∶243-257.
|
[6]Simon K, Rotter K, Zalewska M, et al.HBV-DNA level in blood-serum as a predictor of geed response to therapy with interferon-al2pha-2b of patients with chronic hepatitis B[J].Med sci Monit, 2000, 6 (5) ∶971~975.
|
[7]苏宝凤, 任健康, 张华, 等.前S1抗原的检测与HBV-DNA及其血清学标志物的相关性探讨[J].现代检验医学杂志, 2005, 20 (2) ∶41-44.
|
[8]唐跃华, 谢健敏, 梁玉全, 等.慢性乙型肝炎患者血清HBeAg、HBV-DNA与肝组织炎症关系的探讨[J].中华传染病杂志, 2005, 23 (5) ∶338-341.
|
[9]王利君, 何思春, 谢元宏, 等.乙型肝炎前S1抗原、HBeAg与HBV-DNA的关系及临床意义[J].四川医学, 2005, 26 (4) ∶453-454.
|